Delivered-To: tjphuhs@gmail.com Received: by 2002:a5d:649e:0:b0:439:fcfb:30e with SMTP id o30csp1389575wri; Mon, 6 Apr 2026 19:44:30 -0700 (PDT) X-Received: by 2002:a05:6214:c26:b0:8a6:d318:4909 with SMTP id 6a1803df08f44-8a7020bf953mr253630736d6.2.1775529870697; Mon, 06 Apr 2026 19:44:30 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1775529870; cv=none; d=google.com; s=arc-20240605; b=j3mHWqivDeibbeDmRtNiuUTE7rFAuS6ZH2vILW+iptaSPVf9/p2pOf7m+9bodSOPj+ pFFFSMBFnc7vSHEO2XdgQbPrTAl1eHtT9qBwEyVtTEE/25j4VwPNYfMew4MwGkXOrf5A cvEwBBDj3CxdJ/qFV5vUR/UPOxQopVkPXl4kzR3/F7tymQqHY0PsrPOWnK15RQZDN4up DGM6IAbJpYXKe+PpkzVHvk+AvuzJ8OQwIyPNBVR6uvdtRgPW+PoZvy2+3wW3shzfpxQs RAOLB2UDp3TMd9vaXy+0blEKpyVDuJxXjlJGyr8C7cke8kVsqhCJSPAeZrbGy7Eyjo2d pf2g== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=list-unsubscribe-post:list-unsubscribe:list-post:list-id :list-archive:list-url:list-owner:reply-to:in-reply-to:references :sender:feedback-id:date:message-id:to:from:subject:mime-version :dkim-signature:dkim-signature; bh=QHjJBcGS/1JOAqBSXjLdyNb1fhQytFsSet+i3qU0jtY=; fh=9zP21OW67FFZD2VV42mGudo540Qp4aalMWxJB5kMYug=; b=TlZGhqaZHFuRGUxotdXYadrqsWtKiaguXcN1Cx2KLpgvnzBsMOh1je4KpDu2ykQzwZ +8iWlCu0J4pebX8gRjpYh/9AEBjkuP7A9SqI7m2Gp6q9vIYXrY+DIRNW4269Sw9EU/MF S2RRJOLOZ2HkmxJqrmvDFhWugrZi2iVvT1JyFRnl40pCqnkm21yW7/j1RT8TkucbTTV6 +hpEUbq/KUx379vlgB15BroXZ79HxNjH+y2ecGxJ+eEcQEr6BlNE+lD47cC6nrSW3qvI uqbxHVc5NLCQmTxsPLp60OUMEAShe0NsLT+alN6eqKv13rzUwqmWhZzWzn53T0sKWAAn z9Uw==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@mg2.substack.com header.s=mailo header.b=wfTLpjc2; dkim=pass header.i=@mailgun.org header.s=mg header.b=FFYDLHz5; spf=pass (google.com: domain of bounce+a6cce7.4d1858-tjphuhs=gmail.com@mg2.substack.com designates 159.112.244.21 as permitted sender) smtp.mailfrom="bounce+a6cce7.4d1858-tjphuhs=gmail.com@mg2.substack.com"; dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=substack.com Return-Path: Received: from v521.v5375b7fa.use4.send.mailgun.net (v521.v5375b7fa.use4.send.mailgun.net. [159.112.244.21]) by mx.google.com with UTF8SMTPS id 6a1803df08f44-8a5973e552fsi181517026d6.289.2026.04.06.19.44.30 for (version=TLS1_2 cipher=ECDHE-ECDSA-AES128-GCM-SHA256 bits=128/128); Mon, 06 Apr 2026 19:44:30 -0700 (PDT) Received-SPF: pass (google.com: domain of bounce+a6cce7.4d1858-tjphuhs=gmail.com@mg2.substack.com designates 159.112.244.21 as permitted sender) client-ip=159.112.244.21; Authentication-Results: mx.google.com; dkim=pass header.i=@mg2.substack.com header.s=mailo header.b=wfTLpjc2; dkim=pass header.i=@mailgun.org header.s=mg header.b=FFYDLHz5; spf=pass (google.com: domain of bounce+a6cce7.4d1858-tjphuhs=gmail.com@mg2.substack.com designates 159.112.244.21 as permitted sender) smtp.mailfrom="bounce+a6cce7.4d1858-tjphuhs=gmail.com@mg2.substack.com"; dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=substack.com DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=mg2.substack.com; q=dns/txt; s=mailo; t=1775529870; x=1775537070; h=List-Unsubscribe-Post: List-Unsubscribe: List-Post: List-Id: List-Archive: List-Owner: Reply-To: In-Reply-To: References: Sender: Sender: Date: Message-Id: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: X-Feedback-Id; bh=QHjJBcGS/1JOAqBSXjLdyNb1fhQytFsSet+i3qU0jtY=; b=wfTLpjc2pH8t9n2GIUmbCdaXG0URmPpPbkJ4nci87I3zvHM/XBMSgq0DKyy6FvB1VdQwto5NwcW2ZsbatyuWFdLBzAIUE7Go1rrzZsK3W/F8iMGixItJUA3ema6gwOj51FOWLqbt8qIbPH7ZXQ5l6tO4J3Wh14pvTI09yPYtHtI= DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=mailgun.org; q=dns/txt; s=mg; t=1775529870; x=1775537070; h=List-Unsubscribe-Post: List-Unsubscribe: List-Post: List-Id: List-Archive: List-Owner: Reply-To: In-Reply-To: References: Sender: Sender: Date: Message-Id: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: X-Feedback-Id; bh=QHjJBcGS/1JOAqBSXjLdyNb1fhQytFsSet+i3qU0jtY=; b=FFYDLHz5lC/sAggwC80Nqj9Qa3K0oVh848YtpG+Ckhi1z227j5WKYWqML+tbHrlkP7BAjd+f4ArcFeqq3Ara692JgomtT8emWH52/dL7ys02gmL7ijCCQ3rlb/h9atV/oa2VoT8mOOkLZ2yB0CqNkf8K+8X+q/RJjkcAo5oBydA= X-Mailgun-Sid: WyIxODZiYSIsInRqcGh1aHNAZ21haWwuY29tIiwiNGQxODU4Il0= X-Feedback-Id: postmaster@mg2.substack.com:post:5a78b6d5cd16820001f2a9d4:mailgun Received: by 44009992b16b40afe86f5f9db23d5829a6a1d23115876e88b0adc3daa4f8b027 with HTTP id 69d46f8e37a549e1de31987c; Tue, 07 Apr 2026 02:44:30 GMT X-Mailgun-Sending-Ip: 159.112.244.21 Mime-Version: 1.0 Content-Type: multipart/alternative; boundary="47b5552554290dcb07a6c975a29c5d26b779380fedb417581b2b1f0ce2b1" Subject: Lipo-C: A Cheaper Energy Alternative To Mitochondrial Peptides From: Derek from Peptide Price To: tjphuhs@gmail.com X-Mailgun-Tag: post X-Mailgun-Track-Clicks: false Message-Id: <20260407024336.3.9a66ec17e93d269b@mg2.substack.com> Date: Tue, 7 Apr 2026 02:43:36 +0000 Feedback-Id: post-193425311:cat-post:pub-3365367:substack Sender: Derek from Peptide Price References: In-Reply-To: Reply-To: Derek from Peptide Price List-Owner: List-Url: List-Archive: List-Id: List-Post: List-Unsubscribe: List-Unsubscribe-Post: List-Unsubscribe=One-Click X-Mailgun-Variables: {"category": "post", "email_generated_at": "1775529870038", "is_freemail": "true", "post_audience": "everyone", "post_id": "193425311", "post_type": "newsletter", "pub_community_enabled": "true", "publication_id": "3365367", "subdomain": "derekpruski", "user_id": "273622398"} --47b5552554290dcb07a6c975a29c5d26b779380fedb417581b2b1f0ce2b1 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable View this post on the web at https://derekpruski.substack.com/p/lipo-c-a-ch= eaper-energy-alternative Research Use Only. Not Medical Advice. Educational Purposes Only. If you=E2=80=99ve been running mitochondrial peptides and hit a wall =E2=80= =94 or you=E2=80=99re looking for something that moves the needle on energy= without the price tag =E2=80=94 this one=E2=80=99s worth a look. Lipo-C wa= s one of the biggest energy movers noticed late in RS cut protocols and it = consistently gets slept on. It=E2=80=99s not replacing SS-31 or MOTS-c, it= =E2=80=99s hitting a completely different pathway underneath them. The cofa= ctor floor those peptides depend on. Think of it like this: a tuned engine = running on empty still doesn=E2=80=99t perform. What Is It? A compounded amino acid and B-vitamin stack that hits fat metabolism, liver= function, and cellular energy at multiple rate-limiting steps simultaneous= ly. Rather than tuning mitochondrial signaling, Lipo-C replenishes the raw = materials those pathways run on =E2=80=94 CoA, carnitine, methyl donors =E2= =80=94 at a fraction of the cost. A Note Before the Breakdown This specific breakdown is based on the EZ Peptide formulation. Lipo-C is n= ot a standardized compound =E2=80=94 every vendor=E2=80=99s version is a bi= t different. Ingredient concentrations, included B-vitamins, and excipients= can vary meaningfully between compounders. Always cross-reference your ven= dor=E2=80=99s COA against what=E2=80=99s listed here before drawing direct = comparisons. The Ingredients L-Carnitine =E2=80=94 50mg The fat shuttle. Physically transports activated fatty acids across the inn= er mitochondrial membrane so they can be burned for energy. Without it, fat= gets stuck outside the mitochondria regardless of everything else being op= timal. L-Inositol =E2=80=94 50mg Insulin signal amplifier. Builds the phospholipid messengers (PI/PIP2/PIP3)= that carry insulin=E2=80=99s signal inside the cell. Supports GLUT4 transl= ocation and glucose uptake downstream of receptor binding. Choline Chloride =E2=80=94 50mg Liver fat exporter. Required to build VLDL particles =E2=80=94 the vehicles= that carry fat out of the liver. Insufficient choline =3D fat accumulates = in hepatocytes. Also donates methyl groups to the SAM cycle (see below). L-Methionine =E2=80=94 25mg Master methyl donor. Converts to SAM, the cofactor for 200+ methylation rea= ctions including DNA methylation, phospholipid synthesis, and neurotransmit= ter production. Kicks off a recycling loop that B12, B6, and choline all su= pport downstream. L-Arginine =E2=80=94 20mg Blood flow support. Substrate for nitric oxide synthase =E2=86=92 produces = NO =E2=86=92 relaxes blood vessel walls =E2=86=92 improves regional perfusi= on. Better delivery of everything else to metabolically active tissue. B5 =E2=80=94 Dexpanthenol =E2=80=94 25mg CoA builder. Converts to Coenzyme A, which is required to activate fatty ac= ids before carnitine can even transport them. B5 and carnitine are a pair = =E2=80=94 CoA is the ignition, carnitine is the transport. B6 =E2=80=94 Pyridoxine =E2=80=94 25mg Amino acid traffic controller. As PLP (active form), cofactor for 140+ reac= tions including transamination and homocysteine clearance. Essential for th= e methyl cycle to run cleanly alongside B12. B12 =E2=80=94 Methylcobalamin =E2=80=94 1mg Methyl cycle closer. The active form of B12 =E2=80=94 no hepatic conversion= needed unlike cyanocobalamin. Cofactor for methionine synthase, which recy= cles homocysteine back to methionine. At 1mg it fully saturates serum B12 r= egardless of intrinsic factor status. Key Synergies Carnitine + B5 =E2=80=94 CoA activates the fatty acid, carnitine transports= it. Neither works at full capacity without the other. Methionine + B12 + B6 + Choline =E2=80=94 Four-layer coverage of the SAM/me= thyl cycle. Each hits a different node of the same pathway, so if one is ra= te-limited the others compensate. Inositol + Choline =E2=80=94 Choline builds structural phospholipids (PC/VL= DL). Inositol builds signaling phospholipids (PI/PIP3). Together they cover= both membrane types. All content research use only. RS terminology throughout. Not for human use= =2E Unsubscribe https://substack.com/redirect/2/eyJlIjoiaHR0cHM6Ly9kZXJla3BydXN= raS5zdWJzdGFjay5jb20vYWN0aW9uL2Rpc2FibGVfZW1haWw_dG9rZW49ZXlKMWMyVnlYMmxrSW= pveU56TTJNakl6T1Rnc0luQnZjM1JmYVdRaU9qRTVNelF5TlRNeE1Td2lhV0YwSWpveE56YzFOV= Ek1T0Rjd0xDSmxlSEFpT2pFNE1EY3dOalU0TnpBc0ltbHpjeUk2SW5CMVlpMHpNelkxTXpZM0lp= d2ljM1ZpSWpvaVpHbHpZV0pzWlY5bGJXRnBiQ0o5LnMyU05vcW1LOEhXaDBldTEyc1ZWVmQxSHo= 4RlFZemJkSUIyYTdEM21rdjQiLCJwIjoxOTM0MjUzMTEsInMiOjMzNjUzNjcsImYiOnRydWUsIn= UiOjI3MzYyMjM5OCwiaWF0IjoxNzc1NTI5ODcwLCJleHAiOjIwOTExMDU4NzAsImlzcyI6InB1Y= i0wIiwic3ViIjoibGluay1yZWRpcmVjdCJ9.jsjF149rNPHnVrhgsq2EO3FwlFfot6wOtHwyspT= rcnk? --47b5552554290dcb07a6c975a29c5d26b779380fedb417581b2b1f0ce2b1 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable = Lipo-C: A Cheaper Energy Alternative To Mitochondrial Peptides @media (max-width: 1024px) { .typography .pullquote-align-left, .typography.editor .pullquote-align-left, .typography .pullquote-align-right, .typography.editor .pullquote-align-right, .typography .pullquote-align-wide, .typography.editor .pullquote-align-wide, .typography .pullquote-align-center, .typography.editor .pullquote-align-center { float: none; margin: 0 auto; width: 100%; max-width: 100%; } } @media all and (-ms-high-contrast: none), (-ms-high-contrast: active) { .typography .markup table.image-wrapper img, .typography.editor .markup table.image-wrapper img, .typography .markup table.kindle-wrapper img, .typography.editor .markup table.kindle-wrapper img { max-width: 550px; } } @media (min-width: 1024px) { .typography:not(:has(#toc)) .captioned-image-container figure:has(> a.ima= ge2-offset-left), .typography.editor:not(:has(#toc)) .captioned-image-container figure:has(= > a.image2-offset-left) { margin-left: var(--image-offset-margin); } .typography:not(:has(#toc)) .captioned-image-container figure:has(> a.ima= ge2-offset-right), .typography.editor:not(:has(#toc)) .captioned-image-container figure:has(= > a.image2-offset-right) { margin-right: var(--image-offset-margin); } } @media (min-width: 1300px) { .typography .captioned-image-container figure:has(> a.image2-offset-left)= , .typography.editor .captioned-image-container figure:has(> a.image2-offse= t-left) { margin-left: var(--image-offset-margin); } .typography .captioned-image-container figure:has(> a.image2-offset-right= ), .typography.editor .captioned-image-container figure:has(> a.image2-offse= t-right) { margin-right: var(--image-offset-margin); } } @media (max-width: 1024px) { .typography, .typography.editor { /* Disable offset on mobile/tablet */ } .typography .captioned-image-container figure:has(> a.image2-align-left), .typography.editor .captioned-image-container figure:has(> a.image2-align= -left), .typography .captioned-image-container figure:has(> a.image2-align-right)= , .typography.editor .captioned-image-container figure:has(> a.image2-align= -right) { float: none; margin: 1em auto; max-width: 100%; width: auto; padding: 0; } .typography .captioned-image-container figure:has(> a.image2-align-left.t= hefp), .typography.editor .captioned-image-container figure:has(> a.image2-align= -left.thefp), .typography .captioned-image-container figure:has(> a.image2-align-right.= thefp), .typography.editor .captioned-image-container figure:has(> a.image2-align= -right.thefp) { margin: 1em auto; } .typography .captioned-image-container figure:has(> a.image2-offset-left)= , .typography.editor .captioned-image-container figure:has(> a.image2-offse= t-left), .typography .captioned-image-container figure:has(> a.image2-offset-right= ), .typography.editor .captioned-image-container figure:has(> a.image2-offse= t-right) { margin: 1em auto; } .typography .captioned-image-container figure:has(> a.image2-align-left) = =2Eimage2-inset, .typography.editor .captioned-image-container figure:has(> a.image2-align= -left) .image2-inset, .typography .captioned-image-container figure:has(> a.image2-align-right)= .image2-inset, .typography.editor .captioned-image-container figure:has(> a.image2-align= -right) .image2-inset { display: block; justify-content: initial; } } @media (max-width: 768px) { .typography .markup div.sponsorship-campaign-embed, .typography.editor .markup div.sponsorship-campaign-embed { margin-top: 24px; margin-bottom: 24px; } .typography .markup div.sponsorship-campaign-embed:first-child, .typography.editor .markup div.sponsorship-campaign-embed:first-child { margin-top: 0px; } } @media screen and (max-width: 650px) { .typography .markup div.youtube-overlay, .typography.editor .markup div.youtube-overlay, .typography .markup div.vimeo-overlay, .typography.editor .markup div.vimeo-overlay { display: none !important; } } @media screen and (max-width: 370px) { .typography .markup div.tiktok-wrap, .typography.editor .markup div.tiktok-wrap { width: calc(95vw - 32px); height: calc((95vw - 32px - 2px) / 0.485714); } } @media screen and (max-width: 650px) { .typography .markup div.embedded-publication-wrap .embedded-publication.s= how-subscribe, .typography.editor .markup div.embedded-publication-wrap .embedded-public= ation.show-subscribe { padding: 24px; } } @media screen and (max-width: 650px) { .typography .markup div.subscription-widget-wrap .subscription-widget.sho= w-subscribe, .typography.editor .markup div.subscription-widget-wrap .subscription-wid= get.show-subscribe, .typography .markup div.subscription-widget-wrap-editor .subscription-wid= get.show-subscribe, .typography.editor .markup div.subscription-widget-wrap-editor .subscript= ion-widget.show-subscribe, .typography .markup div.captioned-button-wrap .subscription-widget.show-s= ubscribe, .typography.editor .markup div.captioned-button-wrap .subscription-widget= =2Eshow-subscribe { padding: 0px 24px; } } @media screen and (max-width: 650px) { .typography .markup div.subscription-widget-wrap .subscription-widget.sho= w-subscribe .subscription-widget-subscribe .button, .typography.editor .markup div.subscription-widget-wrap .subscription-wid= get.show-subscribe .subscription-widget-subscribe .button, .typography .markup div.subscription-widget-wrap-editor .subscription-wid= get.show-subscribe .subscription-widget-subscribe .button, .typography.editor .markup div.subscription-widget-wrap-editor .subscript= ion-widget.show-subscribe .subscription-widget-subscribe .button, .typography .markup div.captioned-button-wrap .subscription-widget.show-s= ubscribe .subscription-widget-subscribe .button, .typography.editor .markup div.captioned-button-wrap .subscription-widget= =2Eshow-subscribe .subscription-widget-subscribe .button { padding: 10px 12px; min-width: 110px; } } @media (max-width: 650px) { .typography .markup .twitter-embed, .typography.editor .markup .twitter-embed, .typography .markup .tweet, .typography.editor .markup .tweet { padding: 12px; } } @media (max-width: 650px) { .typography .markup .twitter-embed .tweet-text, .typography.editor .markup .twitter-embed .tweet-text, .typography .markup .tweet .tweet-text, .typography.editor .markup .tweet .tweet-text { font-size: 14px; line-height: 20px; } } @media (max-width: 650px) { .typography .markup .twitter-embed .tweet-photos-container.two, .typography.editor .markup .twitter-embed .tweet-photos-container.two, .typography .markup .tweet .tweet-photos-container.two, .typography.editor .markup .tweet .tweet-photos-container.two, .typography .markup .twitter-embed .tweet-photos-container.three, .typography.editor .markup .twitter-embed .tweet-photos-container.three, .typography .markup .tweet .tweet-photos-container.three, .typography.editor .markup .tweet .tweet-photos-container.three, .typography .markup .twitter-embed .tweet-photos-container.four, .typography.editor .markup .twitter-embed .tweet-photos-container.four, .typography .markup .tweet .tweet-photos-container.four, .typography.editor .markup .tweet .tweet-photos-container.four { height: 200px; } } @media (max-width: 650px) { .typography .markup .twitter-embed a.expanded-link .expanded-link-img, .typography.editor .markup .twitter-embed a.expanded-link .expanded-link-= img, .typography .markup .tweet a.expanded-link .expanded-link-img, .typography.editor .markup .tweet a.expanded-link .expanded-link-img { max-height: 180px; } } @media (max-width: 650px) { .typography .markup .twitter-embed a.expanded-link .expanded-link-descrip= tion, .typography.editor .markup .twitter-embed a.expanded-link .expanded-link-= description, .typography .markup .tweet a.expanded-link .expanded-link-description, .typography.editor .markup .tweet a.expanded-link .expanded-link-descript= ion { display: none; } } @media screen and (max-width: 650px) { .typography .markup .apple-podcast-container, .typography.editor .markup .apple-podcast-container { width: unset; } } @media (max-width: 420px) { .typography .markup .install-substack-app-embed img.install-substack-app-= embed-img, .typography.editor .markup .install-substack-app-embed img.install-substa= ck-app-embed-img { margin: 0 auto 16px auto; } } @media (max-width: 420px) { .typography .markup .install-substack-app-embed .install-substack-app-emb= ed-text, .typography.editor .markup .install-substack-app-embed .install-substack-= app-embed-text { margin: 0 0 12px 0; max-width: 100%; width: auto; text-align: center; } } @media (max-width: 420px) { .typography .markup .install-substack-app-embed .install-substack-app-emb= ed-link, .typography.editor .markup .install-substack-app-embed .install-substack-= app-embed-link { display: flex; justify-content: center; } } @media screen and (min-width: 481px) { .share-button-container { height: 38px; } } @media screen and (min-width: 481px) { .share-button-container a.comment { height: 38px; line-height: 38px; padding-right: 10px; } } @media screen and (max-width: 480px) { .share-button-container .separator { display: block; margin: 0; height: 8px; border-left: none; } } @media screen and (max-width: 480px) { .share-button-container a.share.first img { padding-left: 0; } } @media screen and (min-width: 481px) { .share-button-container a.mobile { display: none !important; } } @media screen and (min-width: 541px) { .settings-add-pub-modal-wrapper .container .add-recommending-pub-modal-co= ntainer { padding: 36px; height: 680px; } } @media screen and (min-width: 541px) { .settings-add-pub-modal-wrapper .container .add-recommending-pub-modal-co= ntainer .footer { position: absolute; bottom: 36px; margin: 0px; } } @media screen and (max-width: 650px) { .header-anchor-parent { display: none; } } @media screen and (max-width: 768px) { .post { padding: 16px 0 0 0; } } @media screen and (max-width: 650px) { .post .post-header .post-label { margin-top: 8px; } } @media screen and (max-width: 650px) { .post .post-header .meta-author-wrap.alternative-meta .meta-right-column = =2Epost-meta { margin-top: 6px; } } @media screen and (max-width: 650px) { .post .footer-facepile-container { height: 64px; padding: 0 16px; display: flex; align-items: center; justify-content: flex-start; width: 100%; } } @media screen and (max-width: 650px) { .post .post-footer.use-separators { justify-content: center; } } @media screen and (max-width: 650px) { .post .post-footer.next-prev { height: 64px; justify-content: space-between; box-sizing: border-box; } } @media screen and (max-width: 650px) { .post-contributor-footer .post-contributor-bio-table { display: block; } .post-contributor-footer .post-contributor-bio-table-row { display: flex; flex-direction: row; } .post-contributor-footer .post-contributor-bio-userhead-cell, .post-contributor-footer .post-contributor-bio-body-cell { display: block; } .post-contributor-footer .post-contributor-bio-body-cell { flex-grow: 1; } .post-contributor-footer .post-contributor-bio-body-table { display: block; } .post-contributor-footer .post-contributor-bio-body-table-row { display: block; } .post-contributor-footer .post-contributor-bio-copy-cell, .post-contributor-footer .post-contributor-bio-controls-cell { display: block; } .post-contributor-footer .post-contributor-bio-copy-cell { margin: 0 0 16px 0; } .post-contributor-footer .post-contributor-bio-controls-cell { width: auto; } .post-contributor-footer .post-contributor-bio-controls { margin: auto; } .post-contributor-footer .post-contributor-bio-controls .button.primary { width: 100%; } .post-contributor-footer .post-contributor-bio-text { font-size: 14px; } } @media screen and (min-width: 768px) { .post-silhouette { padding: 32px 0; } } @media screen and (max-width: 650px) { .post-silhouette .post-silhouette-title { margin-top: 10.44225025px; height: 120px; } } @media screen and (max-width: 650px) { .post-silhouette .post-silhouette-meta { width: 75%; } } @media screen and (max-width: 650px) { .post-silhouette .post-silhouette-meta.with-byline-image { margin: 20px 0; } } @media screen and (max-width: 650px) { .use-theme-bg .post-meta.alternative-meta .post-meta-item, .post-meta.alternative-meta .post-meta-item { padding-right: 16px; } } @media screen and (max-width: 370px) { .use-theme-bg .post-meta.alternative-meta .post-meta-item, .post-meta.alternative-meta .post-meta-item { font-size: 14px; } } @media screen and (max-width: 650px) { .use-theme-bg .post-meta.alternative-meta .post-meta-item.guest-author-pu= blication, .post-meta.alternative-meta .post-meta-item.guest-author-publication { display: none; } } @media screen and (max-width: 370px) { .post-meta .post-meta-item .post-meta-button { height: 36px !important; /* important to override in-line height style on emails */ } .post-meta .post-meta-item .post-meta-button .meta-button-label { display: none; } .post-meta .post-meta-item .post-meta-button > svg { margin-right: 0; } } @media screen and (max-width: 370px) { .post-meta .post-meta-item { font-size: 12px; } } @media screen and (max-width: 650px) { .post .floating-subscribe-button { bottom: 20px; right: 20px; } } @media (max-width: 1024px) { body .pullquote-align-left, body .pullquote-align-right, body .pullquote-align-wide, body .pullquote-align-center { float: none; margin: 0 auto; width: 100%; max-width: 100%; } } @media all and (-ms-high-contrast: none), (-ms-high-contrast: active) { body .markup table.image-wrapper img, body .markup table.kindle-wrapper img { max-width: 550px; } } @media (min-width: 1024px) { body:not(:has(#toc)) .captioned-image-container figure:has(> a.image2-off= set-left) { margin-left: var(--image-offset-margin); } body:not(:has(#toc)) .captioned-image-container figure:has(> a.image2-off= set-right) { margin-right: var(--image-offset-margin); } } @media (min-width: 1300px) { body .captioned-image-container figure:has(> a.image2-offset-left) { margin-left: var(--image-offset-margin); } body .captioned-image-container figure:has(> a.image2-offset-right) { margin-right: var(--image-offset-margin); } } @media (max-width: 1024px) { body { /* Disable offset on mobile/tablet */ } body .captioned-image-container figure:has(> a.image2-align-left), body .captioned-image-container figure:has(> a.image2-align-right) { float: none; margin: 1em auto; max-width: 100%; width: auto; padding: 0; } body .captioned-image-container figure:has(> a.image2-align-left.thefp), body .captioned-image-container figure:has(> a.image2-align-right.thefp) = { margin: 1em auto; } body .captioned-image-container figure:has(> a.image2-offset-left), body .captioned-image-container figure:has(> a.image2-offset-right) { margin: 1em auto; } body .captioned-image-container figure:has(> a.image2-align-left) .image2= -inset, body .captioned-image-container figure:has(> a.image2-align-right) .image= 2-inset { display: block; justify-content: initial; } } @media (max-width: 768px) { body .markup div.sponsorship-campaign-embed { margin-top: 24px; margin-bottom: 24px; } body .markup div.sponsorship-campaign-embed:first-child { margin-top: 0px; } } @media screen and (max-width: 650px) { body .markup div.youtube-overlay, body .markup div.vimeo-overlay { display: none !important; } } @media screen and (max-width: 370px) { body .markup div.tiktok-wrap { width: calc(95vw - 32px); height: calc((95vw - 32px - 2px) / 0.485714); } } @media screen and (max-width: 650px) { body .markup div.embedded-publication-wrap .embedded-publication.show-sub= scribe { padding: 24px; } } @media screen and (max-width: 650px) { body .markup div.subscription-widget-wrap .subscription-widget.show-subsc= ribe, body .markup div.subscription-widget-wrap-editor .subscription-widget.sho= w-subscribe, body .markup div.captioned-button-wrap .subscription-widget.show-subscrib= e { padding: 0px 24px; } } @media screen and (max-width: 650px) { body .markup div.subscription-widget-wrap .subscription-widget.show-subsc= ribe .subscription-widget-subscribe .button, body .markup div.subscription-widget-wrap-editor .subscription-widget.sho= w-subscribe .subscription-widget-subscribe .button, body .markup div.captioned-button-wrap .subscription-widget.show-subscrib= e .subscription-widget-subscribe .button { padding: 10px 12px; min-width: 110px; } } @media (max-width: 650px) { body .markup .twitter-embed, body .markup .tweet { padding: 12px; } } @media (max-width: 650px) { body .markup .twitter-embed .tweet-text, body .markup .tweet .tweet-text { font-size: 14px; line-height: 20px; } } @media (max-width: 650px) { body .markup .twitter-embed .tweet-photos-container.two, body .markup .tweet .tweet-photos-container.two, body .markup .twitter-embed .tweet-photos-container.three, body .markup .tweet .tweet-photos-container.three, body .markup .twitter-embed .tweet-photos-container.four, body .markup .tweet .tweet-photos-container.four { height: 200px; } } @media (max-width: 650px) { body .markup .twitter-embed a.expanded-link .expanded-link-img, body .markup .tweet a.expanded-link .expanded-link-img { max-height: 180px; } } @media (max-width: 650px) { body .markup .twitter-embed a.expanded-link .expanded-link-description, body .markup .tweet a.expanded-link .expanded-link-description { display: none; } } @media screen and (max-width: 650px) { body .markup .apple-podcast-container { width: unset; } } @media (max-width: 420px) { body .markup .install-substack-app-embed img.install-substack-app-embed-i= mg { margin: 0 auto 16px auto; } } @media (max-width: 420px) { body .markup .install-substack-app-embed .install-substack-app-embed-text= { margin: 0 0 12px 0; max-width: 100%; width: auto; text-align: center; } } @media (max-width: 420px) { body .markup .install-substack-app-embed .install-substack-app-embed-link= { display: flex; justify-content: center; } } @media screen and (min-width: 500px) { body .header a.logo { width: 42px; height: 42px; border-radius: 12px; } } @media screen and (max-width: 420px) { body .subscription-receipt table:first-of-type .subscription-amount .subs= cription-discount { width: 72px !important; } } @media screen and (min-width: 481px) { body .share-button-container { height: auto; } } @media screen and (max-width: 480px) { body .share-button-container .separator { display: block !important; margin: 0 !important; height: 8px !important; border-left: none !important; } } @media screen and (max-width: 650px) { .digest .item .post-meta-item.audience { display: none; } } @media screen and (min-width: 500px) { .digest-publication .logo img { width: 42px; height: 42px; border-radius: 8px; } } @media screen and (max-width: 650px) { .comments-page .container .comment-list .collapsed-reply { margin-left: calc(10 + 32px - 24px); } } @media screen and (max-width: 650px) { .comment > .comment-list { padding-left: 24px; } } @media screen and (max-width: 650px) { .finish-magic-login-modal .modal-content .container { padding: 24px 0; } } @media (max-width: 650px) { .reader2-text-b3 { line-height: 24px; } } @media screen and (max-width: 650px) { .reader2-text-h4 { line-height: 24px; } } @media screen and (min-width: 541px) { .user-profile-modal { padding-left: 12px; padding-right: 12px; } } @media screen and (max-width: 650px) { .subscribe-widget form.form .sideBySideWrap button.rightButton { padding: 10px 12px; } } @media screen and (min-width: 541px) { .pub-icon:hover .logo-hover, .feed-item-icon:hover .logo-hover { display: block; } } @media screen and (max-width: 650px) { .post-ufi.single-full-width-button .post-ufi-button-wrapper { width: 100%; padding: 16px; } .post-ufi.single-full-width-button .post-ufi-button-wrapper:empty { display: none; } .post-ufi.single-full-width-button .post-ufi-button { width: 100%; justify-content: center; } } @media screen and (max-width: 768px) { .file-embed-wrapper { padding: 0; } } @media screen and (max-width: 768px) { .file-embed-wrapper-editor { padding: 0; } } @media screen and (max-width: 768px) { .file-embed-wrapper-editor:active { padding: 0; } } @media only screen and (max-width: 650px) { .file-embed-button.wide, .file-embed-error-button.wide { display: none; } } @media only screen and (min-width: 630px) { .file-embed-button.narrow, .file-embed-error-button.narrow { display: none; } } @media screen and (min-width: 541px) { .audio-player-wrapper .audio-player { min-width: 500px; } } @media screen and (max-width: 650px) { .audio-player-wrapper .audio-player .audio-player-progress { border-left-width: 16px; border-right-width: 16px; } } @media screen and (max-width: 650px) { .audio-player-wrapper .audio-player .audio-player-progress .audio-player-= progress-bar .audio-player-progress-bar-popup { top: -54px; } } @media screen and (max-width: 650px) { .audio-player-wrapper-fancy .audio-player .audio-player-progress { border-left-width: 16px; border-right-width: 16px; } } @media screen and (max-width: 650px) { .audio-player-wrapper-fancy .audio-player .audio-player-progress .audio-p= layer-progress-bar .audio-player-progress-bar-popup { top: -54px; } } @media (min-width: 250px) { .audio-player-wrapper-fancy .audio-player { padding: 32px; } .audio-player-wrapper-fancy .audio-player .btn-group { display: flex; } .audio-player-wrapper-fancy .audio-player .btn-group .button:last-of-type= { display: block; } } @media (min-width: 300px) { .audio-player-wrapper-fancy .audio-player .btn-group { display: block; } .audio-player-wrapper-fancy .audio-player .btn-group .button:first-of-typ= e { display: block; } } @media (min-width: 350px) { .audio-player-wrapper-fancy .audio-player .audio-player-substack-logo { display: block; } .audio-player-wrapper-fancy .audio-player .audio-player-title { margin-top: 16px; } .audio-player-wrapper-fancy .audio-player .audio-player-hero-image-contai= ner { padding-top: 15%; width: 15%; display: block; } .audio-player-wrapper-fancy .audio-player .btn-group .button:first-of-typ= e { display: block; } .audio-player-wrapper-fancy .audio-player .audio-player-substack-logo { display: block; } } @media (min-width: 350px) { .audio-player-wrapper-fancy .audio-player .audio-player-hero-image-contai= ner { padding-top: 25%; width: 25%; display: block; } .audio-player-wrapper-fancy .audio-player .btn-group { display: flex; } .audio-player-wrapper-fancy .audio-player .btn-group .button:first-of-typ= e { display: block; } } @media (min-width: 400px) { .audio-player-wrapper-fancy .audio-player .audio-player-hero-image-contai= ner { padding-top: 40%; width: 40%; } } @media (max-width: 400px) { .audio-player-wrapper-fancy .audio-player .btn-group { margin-top: 12px; } .audio-player-wrapper-fancy .audio-player .btn-group .button { font-size: 13px; padding: 6px 12px; height: auto; margin-top: 10px; } } @media (min-width: 600px) { .audio-player-wrapper-fancy .audio-player .audio-player-hero-image-contai= ner { padding-top: 55%; width: 55%; } } @media (max-width: 650px) { .poll-editor-modal { min-width: calc(100% - 20px); } } @media (max-width: 750px) { .poll-embed .poll-anchor-target .poll-anchor-copy-button { left: 8px; top: 45px; } } @media not all and (min-resolution: 0.001dpcm) { @supports (-webkit-appearance: none) { p a:not(.primary.button), .post p:not(.button-wrapper) a:not(.primary.button), .footnote a.footnote-anchor:not(.primary.button), .thread-head .markup p:not(.button-wrapper) a:not(.primary.button) { color: #ff6719; text-decoration: none; } p a:not(.primary.button):hover, .post p:not(.button-wrapper) a:not(.primary.button):hover, .footnote a.footnote-anchor:not(.primary.button):hover, .thread-head .markup p:not(.button-wrapper) a:not(.primary.button):hove= r { text-decoration: underline; } } }3D""
Research Use Only.
͏     ­͏     = ­͏     ­͏     ­͏  =   ­͏     ­͏     ­T= 7;     ­͏     ­͏     &= #173;͏     ­͏     ­͏   =   ­͏     ­͏     ­͏= ;     ­͏     ­͏     &#= 173;͏     ­͏     ­͏   &= #8199; ­͏     ­͏     ­͏=     ­͏     ­͏     = 73;͏     ­͏     ­͏   &#= 8199; ­͏     ­͏     ­͏ =     ­͏     ­͏     = 3;͏     ­͏     ­͏   = 199; ­͏     ­͏     ­͏ &= nbsp;   ­͏     ­͏     ­= ;͏     ­͏     ­͏   Q= 99; ­͏     ­͏     ­͏ &n= bsp;   ­͏     ­͏     ­= ͏     ­͏     ­͏   ̳= 9; ­͏     ­͏     ­͏ &nb= sp;   ­͏     ­͏     ­&= #847;     ­͏     ­͏    = ; ­͏     ­͏     ­͏ &nbs= p;   ­͏     ­͏     ­&#= 847;     ­͏     ­͏    = ­͏     ­͏     ­͏  = ;   ­͏     ­͏     ­= 47;     ­͏     ­͏     = ­͏     ­͏     ­͏  =   ­͏     ­͏     ­T= 7;     ­͏     ­͏     &= #173;͏     ­͏     ­͏   =   ­͏     ­͏     ­͏= ;     ­͏     ­͏     &#= 173;͏     ­͏     ­͏   &= #8199; ­͏     ­͏     ­͏=     ­͏     ­͏     = 73;͏     ­͏     ­͏   &#= 8199; ­͏     ­͏     ­͏ =     ­͏     ­͏     = 3;͏     ­͏     ­͏   = 199; ­͏     ­͏     ­͏ &= nbsp;   ­͏     ­͏     ­= ;͏     ­͏     ­͏   Q= 99; ­͏     ­͏     ­͏ &n= bsp;   ­͏     ­͏     ­= ͏     ­͏     ­͏   ̳= 9; ­͏     ­͏     ­͏ &nb= sp;   ­͏     ­͏     ­&= #847;     ­͏     ­͏    = ; ­͏     ­͏     ­͏ &nbs= p;   ­͏     ­͏     ­&#= 847;     ­͏     ­͏    = ­͏     ­͏     ­͏  = ;   ­͏     ­͏     ­= 47;     ­͏     ­͏     = ­͏     ­͏     ­͏  =   ­͏     ­͏     ­T= 7;     ­͏     ­͏     &= #173;͏     ­͏     ­͏   =   ­͏     ­͏     ­͏= ;     ­͏     ­͏     &#= 173;͏     ­͏     ­͏   &= #8199; ­͏     ­͏     ­͏=     ­͏     ­͏     = 73;͏     ­͏     ­͏   &#= 8199; ­͏     ­͏     ­͏ =     ­͏     ­͏     = 3;͏     ­͏     ­͏   = 199; ­͏     ­͏     ­͏ &= nbsp;   ­͏     ­͏     ­= ;͏     ­͏     ­͏   Q= 99; ­͏     ­͏     ­͏ &n= bsp;   ­͏     ­͏     ­=
=
 =
3D""
= 3D""
3D""
3D""
READ IN= APP3D""
=  

Research Use Only. Not Medical Advice. Educational Purposes Only.

If you’ve been running mitochondrial peptides and hit a= wall — or you’re looking for something that moves the needle o= n energy without the price tag — this one’s worth a look. Lipo-= C was one of the biggest energy movers noticed late in RS cut protocols and= it consistently gets slept on. It’s not replacing SS-31 or MOTS-c, i= t’s hitting a completely different pathway underneath them. The cofac= tor floor those peptides depend on. Think of it like this: a tuned engine r= unning on empty still doesn’t perform.

What Is It?

A compounded a= mino acid and B-vitamin stack that hits fat metabolism, liver function, and= cellular energy at multiple rate-limiting steps simultaneously. Rather tha= n tuning mitochondrial signaling, Lipo-C replenishes the raw materials thos= e pathways run on — CoA, carnitine, methyl donors — at a fracti= on of the cost.

A Note Before the Breakdown

The Ingredients

L-Carnitine ̵= 2; 50mg

The fat shuttle. Physically= transports activated fatty acids across the inner mitochondrial membrane s= o they can be burned for energy. Without it, fat gets stuck outside the mit= ochondria regardless of everything else being optimal.

L-Inositol — 50mg

Insulin signal ampli= fier. Builds the phospholipid messengers (PI/PIP2/PIP3) that= carry insulin’s signal inside the cell. Supports GLUT4 translocation= and glucose uptake downstream of receptor binding.

Liver fat exporter= =2E Required to build VL= DL particles — the vehicles that= carry fat out of the liver. Insufficient choline =3D fat accumulates in he= patocytes. Also donates methyl groups to the SAM cycle (see below).<= /p>

L-Methionine — 25mg

Master= methyl donor. Converts to SAM, the cofactor for 200+ methyl= ation reactions including DNA methylation, phospholipid synthesis, and neur= otransmitter production. Kicks off a recycling loop that B12, B6, and choli= ne all support downstream.

L-Arginine — 20mg=

Blood flow support. Substrate for = nitric oxide synthase → produces NO → relaxes blood vessel wall= s → improves regional perfusion. Better delivery of everything else t= o metabolically active tissue.

B5 — Dexpanth= enol — 25mg

CoA builder. Conv= erts to Coenzyme A, which is required to activate fatty acids before carnit= ine can even transport them. B5 and carnitine are a pair — CoA is the= ignition, carnitine is the transport.

B6 — = Pyridoxine — 25mg

Amino acid traffic control= ler. As PLP (active form), cofactor for 140+ reactions inclu= ding transamination and homocysteine clearance. Essential for the methyl cy= cle to run cleanly alongside B12.

B12 — Meth= ylcobalamin — 1mg

Methyl cycle closer. The active form of B12 — no hepatic conversion needed unlik= e cyanocobalamin. Cofactor for methionine synthase, which recycles homocyst= eine back to methionine. At 1mg it fully saturates serum B12 regardless of = intrinsic factor status.

Key Synergies

Carnitine + B5 — CoA activates the fatty = acid, carnitine transports it. Neither works at full capacity without the o= ther.

Methionine + B12 + B6 + Choline — Four-layer coverage of the SAM/methyl cycle. Each hits a d= ifferent node of the same pathway, so if one is rate-limited the others com= pensate.

Inositol + Choline &= #8212; Choline builds structural phospholipids (PC/VLDL). Inositol builds s= ignaling phospholipids (PI/PIP3). Together they cover both membrane types.<= /span>

All content research use only. RS terminology thro= ughout. Not for human use.

Upgrade to paid
=

You're currently a free subscriber to Peptide Price. For the full experience, upgrade your subscription.

Upgrade to paid

3D""
=
 
=
=3D""S= hare
 
 
= =
3D""Like
3D""Comment
<= table role=3D"presentation" width=3D"auto" border=3D"0" cellspacing=3D"0" c= ellpadding=3D"0">
3D""Restack
=
 
© 2026 Derek Pruski
548 Market Street = PMB 72296, San Francisco, CA 94104
Unsubscribe

3D"" --47b5552554290dcb07a6c975a29c5d26b779380fedb417581b2b1f0ce2b1--